Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Walldius

Showing results (61-70 of 82) with videos related to

Pageof 9
Sort By:
Journal of Vascular Research|July 1, 1993
Two-dimensional tortuosity of the superficial femoral artery in early atherosclerosisO Smedby, N Högman, S Nilsson, et al.
Journal of Internal Medicine|April 25, 2006
Errors that result from using the TC/HDL C ratio rather than the apoB/apoA-I ratio to identify the lipoprotein-related risk of vascular diseaseA D Sniderman, I Jungner, I Junger, et al.
Journal of Internal Medicine|May 4, 2010
Renal function assessed by two different formulas and incidence of myocardial infarction and death in middle-aged men and womenM J Holzmann, T Ivert, I Jungner, et al.
Atherosclerosis|September 30, 1994
Influence of lipoprotein lipids, dietary fat and smoking on macrophage degradation of native and oxidized low density lipoproteinJ Regnström, G Walldius, K Hådell, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|August 1, 1995
Probucol treatment decreases serum concentrations of diet-derived antioxidantsL S Elinder, K Hådell, J Johansson, et al.
Upsala Journal of Medical Sciences|October 28, 1998
The ability of non-invasive physiological tests to detect arterial occlusions in the lower extremity. An ROC study with particular regard to recruitment of patients for clinical trialsS Nilsson, U Eriksson, J Johansson, et al.
Lancet (London, England)|July 4, 1987
Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarctionA Hamsten, U de Faire, G Walldius, et al.
Annals of the Rheumatic Diseases|June 17, 2010
Lipids, myocardial infarction and ischaemic stroke in patients with rheumatoid arthritis in the Apolipoprotein-related Mortality RISk (AMORIS) StudyA G Semb, T K Kvien, A H Aastveit, et al.
Acta Radiologica (Stockholm, Sweden : 1987)|May 1, 1988
Quantitation of atherosclerosis in femoral arteriography with ECG gated exposuresS Nilsson, I Berglund, H Bylund, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|October 19, 2016
Low fructosamine and mortality - A long term follow-up of 215,011 non-diabetic subjects in the Swedish AMORIS studyH Malmström, P E Wändell, M J Holzmann, et al.
Pageof 9

Showing results (61-70 of 82) with videos related to

Sort By:
Pageof 9
Journal of Vascular Research|July 1, 1993
Two-dimensional tortuosity of the superficial femoral artery in early atherosclerosisO Smedby, N Högman, S Nilsson, et al.
Journal of Internal Medicine|April 25, 2006
Errors that result from using the TC/HDL C ratio rather than the apoB/apoA-I ratio to identify the lipoprotein-related risk of vascular diseaseA D Sniderman, I Jungner, I Junger, et al.
Journal of Internal Medicine|May 4, 2010
Renal function assessed by two different formulas and incidence of myocardial infarction and death in middle-aged men and womenM J Holzmann, T Ivert, I Jungner, et al.
Atherosclerosis|September 30, 1994
Influence of lipoprotein lipids, dietary fat and smoking on macrophage degradation of native and oxidized low density lipoproteinJ Regnström, G Walldius, K Hådell, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|August 1, 1995
Probucol treatment decreases serum concentrations of diet-derived antioxidantsL S Elinder, K Hådell, J Johansson, et al.
Upsala Journal of Medical Sciences|October 28, 1998
The ability of non-invasive physiological tests to detect arterial occlusions in the lower extremity. An ROC study with particular regard to recruitment of patients for clinical trialsS Nilsson, U Eriksson, J Johansson, et al.
Lancet (London, England)|July 4, 1987
Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarctionA Hamsten, U de Faire, G Walldius, et al.
Annals of the Rheumatic Diseases|June 17, 2010
Lipids, myocardial infarction and ischaemic stroke in patients with rheumatoid arthritis in the Apolipoprotein-related Mortality RISk (AMORIS) StudyA G Semb, T K Kvien, A H Aastveit, et al.
Acta Radiologica (Stockholm, Sweden : 1987)|May 1, 1988
Quantitation of atherosclerosis in femoral arteriography with ECG gated exposuresS Nilsson, I Berglund, H Bylund, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|October 19, 2016
Low fructosamine and mortality - A long term follow-up of 215,011 non-diabetic subjects in the Swedish AMORIS studyH Malmström, P E Wändell, M J Holzmann, et al.
Pageof 9